Literature DB >> 26109815

Prevalence and predictors of hospitalization in Crohn's disease in a prospective population-based inception cohort from 2000-2012.

Petra A Golovics1, Laszlo Lakatos1, Michael D Mandel1, Barbara D Lovasz1, Zsuzsanna Vegh1, Zsuzsanna Kurti1, Istvan Szita1, Lajos S Kiss1, Tunde Pandur1, Peter L Lakatos1.   

Abstract

AIM: To analyze the prevalence, length and predictors of hospitalization in the biological era in the population-based inception cohort from Veszprem province.
METHODS: Data of 331 incident Crohn's disease (CD) patients diagnosed between January 1, 2000 and December 31, 2010 were analyzed (median age at diagnosis: 28; IQR: 21-40 years). Both in- and outpatient records were collected and comprehensively reviewed.
RESULTS: Probabilities of first CD-related hospitalization and re-hospitalization were 32.3%, 45.5%, 53.7% and 13.6%, 23.9%, 29.8%, respectively after one, three and five years of follow-up in Kaplan-Meier analysis. First-year hospitalizations were related to diagnostic procedures (37%), surgery or disease activity (27% and 21%). Non-inflammatory disease behavior at diagnosis (HR = 1.32, P = 0.001) and perianal disease (HR = 1.47, P = 0.04) were associated with time to first CD-related hospitalization, while disease behavior change (HR = 2.38, P = 0.002) and need for steroids (HR = 3.14, P = 0.003) were associated with time to first re-hospitalization in multivariate analyses. Early CD-related hospitalization (within the year of diagnosis) was independently associated with need for immunosuppressives (OR = 2.08, P = 0.001) and need for surgeries (OR = 7.25, P < 0.001) during the disease course.
CONCLUSION: Hospitalization and re-hospitalization rates are still high in this cohort, especially during the first-year after the diagnosis. Non-inflammatory disease behavior at diagnosis was identified as the pivotal predictive factor of both hospitalization and re-hospitalization.

Entities:  

Keywords:  Biological therapy; Crohn’s disease; Hospitalization; Population-based; Predictor; Recurrence

Mesh:

Substances:

Year:  2015        PMID: 26109815      PMCID: PMC4476890          DOI: 10.3748/wjg.v21.i23.7272

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  24 in total

Review 1.  Hospitalisations and surgery in Crohn's disease.

Authors:  Charles N Bernstein; Edward V Loftus; Siew C Ng; Peter L Lakatos; Bjorn Moum
Journal:  Gut       Date:  2012-01-20       Impact factor: 23.059

2.  Hospitalisation, surgical and medical recurrence rates in inflammatory bowel disease 2003-2011—a Danish population-based cohort study.

Authors:  Marianne K Vester-Andersen; Ida Vind; Michelle V Prosberg; Bo G Bengtsson; Thomas Blixt; Pia Munkholm; Mikael Andersson; Tine Jess; Flemming Bendtsen
Journal:  J Crohns Colitis       Date:  2014-08-22       Impact factor: 9.071

Review 3.  Treat to target: a proposed new paradigm for the management of Crohn's disease.

Authors:  Guillaume Bouguen; Barrett G Levesque; Brian G Feagan; Arthur Kavanaugh; Laurent Peyrin-Biroulet; Jean-Frederic Colombel; Stephen B Hanauer; William J Sandborn
Journal:  Clin Gastroenterol Hepatol       Date:  2013-09-10       Impact factor: 11.382

4.  Outcomes of patients with Crohn's disease improved from 1988 to 2008 and were associated with increased specialist care.

Authors:  Geoffrey C Nguyen; Zoann Nugent; Souradet Shaw; Charles N Bernstein
Journal:  Gastroenterology       Date:  2011-03-31       Impact factor: 22.682

5.  Initial disease course and treatment in an inflammatory bowel disease inception cohort in Europe: the ECCO-EpiCom cohort.

Authors:  Johan Burisch; Natalia Pedersen; Silvja Cukovic-Cavka; Niksa Turk; Ioannis Kaimakliotis; Dana Duricova; Olga Shonová; Ida Vind; Søren Avnstrøm; Niels Thorsgaard; Susanne Krabbe; Vibeke Andersen; Frederik Dahlerup Jens; Jens Kjeldsen; Riina Salupere; Jóngerð Olsen; Kári Rubek Nielsen; Pia Manninen; Pekka Collin; Konstantinnos H Katsanos; Epameinondas V Tsianos; Karin Ladefoged; Laszlo Lakatos; Yvonne Bailey; Colm O'Morain; Doron Schwartz; Selwyn Odes; Matteo Martinato; Silvia Lombardini; Laimas Jonaitis; Limas Kupcinskas; Svetlana Turcan; Louisa Barros; Fernando Magro; Daniela Lazar; Adrian Goldis; Inna Nikulina; Elena Belousova; Alberto Fernandez; Vicent Hernandez; Sven Almer; Yaroslava Zhulina; Jonas Halfvarson; Her-Hsin Tsai; Shaji Sebastian; Peter Laszlo Lakatos; Ebbe Langholz; Pia Munkholm
Journal:  Inflamm Bowel Dis       Date:  2014-01       Impact factor: 5.325

6.  Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.

Authors:  Peter Laszlo Lakatos; Petra Anna Golovics; Gyula David; Tunde Pandur; Zsuzsanna Erdelyi; Agnes Horvath; Gabor Mester; Mihaly Balogh; Istvan Szipocs; Csaba Molnar; Erzsebet Komaromi; Gabor Veres; Barbara Dorottya Lovasz; Miklos Szathmari; Lajos S Kiss; Laszlo Lakatos
Journal:  Am J Gastroenterol       Date:  2012-01-10       Impact factor: 10.864

7.  Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study.

Authors:  Laszlo Lakatos; Tunde Pandur; Gyula David; Zsuzsanna Balogh; Pal Kuronya; Arpad Tollas; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

8.  Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease.

Authors:  Peter Laszlo Lakatos; Zsofia Czegledi; Tamas Szamosi; Janos Banai; Gyula David; Ferenc Zsigmond; Tunde Pandur; Zsuzsanna Erdelyi; Orsolya Gemela; Janos Papp; Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

Review 9.  The burden of inflammatory bowel disease in Europe.

Authors:  Johan Burisch; Tine Jess; Matteo Martinato; Peter L Lakatos
Journal:  J Crohns Colitis       Date:  2013-02-08       Impact factor: 9.071

Review 10.  Inflammatory bowel disease course in Crohn's disease: is the natural history changing?

Authors:  Petra A Golovics; Michael D Mandel; Barbara D Lovasz; Peter L Lakatos
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

View more
  12 in total

1.  Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review.

Authors:  Mathurin Fumery; Siddharth Singh; Parambir S Dulai; Corinne Gower-Rousseau; Laurent Peyrin-Biroulet; William J Sandborn
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-16       Impact factor: 11.382

2.  Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.

Authors:  Daniela Simian; Daniela Fluxá; Lilian Flores; Jaime Lubascher; Patricio Ibáñez; Carolina Figueroa; Udo Kronberg; Raúl Acuña; Mauricio Moreno; Rodrigo Quera
Journal:  World J Gastroenterol       Date:  2016-06-14       Impact factor: 5.742

3.  Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.

Authors:  Remo Panaccione; A Hillary Steinhart; Brian Bressler; Reena Khanna; John K Marshall; Laura Targownik; Waqqas Afif; Alain Bitton; Mark Borgaonkar; Usha Chauhan; Brendan Halloran; Jennifer Jones; Erin Kennedy; Grigorios I Leontiadis; Edward V Loftus; Jonathan Meddings; Paul Moayyedi; Sanjay Murthy; Sophie Plamondon; Greg Rosenfeld; David Schwartz; Cynthia H Seow; Chadwick Williams; Charles N Bernstein
Journal:  J Can Assoc Gastroenterol       Date:  2018-07-10

4.  A multicenter, prospective, observational study of the long-term outcomes of Crohn's disease patients under routine care management in Greece.

Authors:  Spyridon Michopoulos; Gregorios Paspatis; Konstantinos Triantafyllou; Spyridon Potamianos; Vassiliki Nikolopoulou; Evangelos Akriviadis; John A Karagiannis; Spyridon Ladas; Maria Tampaki; Charalambos Tzathas
Journal:  Ann Gastroenterol       Date:  2018-07-20

5.  Hospitalization and surgery rates in patients with inflammatory bowel disease in Brazil: a time-trend analysis.

Authors:  Flávia Gonçalves Musauer Palacio; Lucila Marieta Perrotta de Souza; Jéssica Pronestino de Lima Moreira; Ronir Raggio Luiz; Heitor Siffert Pereira de Souza; Cyrla Zaltman
Journal:  BMC Gastroenterol       Date:  2021-04-27       Impact factor: 3.067

6.  Crohn's disease: a population-based study of surgery in the age of biological therapy.

Authors:  Christian Stöss; Maximilian Berlet; Stefan Reischl; Ulrich Nitsche; Marie-Christin Weber; Helmut Friess; Dirk Wilhelm; Philipp-Alexander Neumann
Journal:  Int J Colorectal Dis       Date:  2021-04-19       Impact factor: 2.571

7.  Development of Clinical Prediction Models for Surgery and Complications in Crohn's Disease.

Authors:  Leonardo Guizzetti; Guangyong Zou; Reena Khanna; Parambir S Dulai; William J Sandborn; Vipul Jairath; Brian G Feagan
Journal:  J Crohns Colitis       Date:  2018-01-24       Impact factor: 9.071

Review 8.  Prevention and Treatment of Stricturing Crohn's Disease - Perspectives and Challenges.

Authors:  Joseph Sleiman; Sara El Ouali; Taha Qazi; Benjamin Cohen; Scott R Steele; Mark E Baker; Florian Rieder
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2020-12-28       Impact factor: 3.869

9.  Development of a prognostic model for one-year surgery risk in Crohn's disease patients: A retrospective study.

Authors:  Jia-Yin Yao; Yi Jiang; Jia Ke; Yi Lu; Jun Hu; Min Zhi
Journal:  World J Gastroenterol       Date:  2020-02-07       Impact factor: 5.742

10.  Disease activity patterns of Crohn's disease in the first 10 years after diagnosis in the population-based IBD South Limburg cohort.

Authors:  Dion Wintjens; Francois Bergey; Edoardo Saccenti; Steven Jeuring; Tim van den Heuvel; Mariëlle Romberg-Camps; Liekele Oostenbrug; Ad Masclee; Vitor Martins Dos Santos; Daisy Jonkers; Marie Pierik
Journal:  J Crohns Colitis       Date:  2020-08-26       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.